B. Roe, Elevated Serum Levels of Interferon????????Inducible Protein???10 in Patients Coinfected with Hepatitis C Virus and HIV, The Journal of Infectious Diseases, vol.196, issue.7, pp.1053-1057, 2007.
DOI : 10.1086/520935

M. Zeremski, M. Markatou, Q. Brown, G. Dorante, S. Cunningham-rundles et al., Interferon gamma-inducible protein 10: a predictive marker of successful treatment response in hepatitis C virus/HIV-coinfected patients, J Acquir Immune Defic Syndr, vol.45, issue.3, pp.262-268, 2007.

A. Antonelli, ??-Chemokine CXCL10 and ??-chemokine CCL2 serum levels in patients with hepatitis C???associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis, Metabolism, vol.57, issue.9, pp.1270-1277, 2008.
DOI : 10.1016/j.metabol.2008.04.023

T. Schwartz, T. Frimurer, B. Holst, M. Rosenkilde, and C. Elling, MOLECULAR MECHANISM OF 7TM RECEPTOR ACTIVATION???A GLOBAL TOGGLE SWITCH MODEL, Annual Review of Pharmacology and Toxicology, vol.46, issue.1, pp.481-519, 2006.
DOI : 10.1146/annurev.pharmtox.46.120604.141218

P. Van-den-steen, S. Husson, P. Proost, J. Van-damme, and G. Opdenakker, Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase, Biochemical and Biophysical Research Communications, vol.310, issue.3, pp.889-896, 2003.
DOI : 10.1016/j.bbrc.2003.09.098

T. Loos, Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation, Blood, vol.112, issue.7, pp.2648-2656, 2008.
DOI : 10.1182/blood-2008-04-149039

M. Gorrell, Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders, Clinical Science, vol.108, issue.4, pp.277-292, 2005.
DOI : 10.1042/CS20040302

A. Ludwig, F. Schiemann, R. Mentlein, B. Lindner, and E. Brandt, Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine, J Leukoc Biol, vol.72, issue.1, pp.183-191, 2002.

P. Proost, Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties, Blood, vol.98, issue.13, pp.3554-3561, 2001.
DOI : 10.1182/blood.V98.13.3554

G. Mcquibban, J. Gong, E. Tam, C. Mcculloch, I. Clark-lewis et al., Inflammation Dampened by Gelatinase A Cleavage of Monocyte Chemoattractant Protein-3, Science, vol.289, issue.5482, pp.1202-1206, 2000.
DOI : 10.1126/science.289.5482.1202

K. Zhang, HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration, Nature Neuroscience, vol.6, issue.10, pp.1064-1071, 2003.
DOI : 10.1038/nn1127

C. Dinarello, Interleukin-18, a proinflammatory cytokine, Eur Cytokine Netw, vol.11, issue.3, pp.483-486, 2000.

G. Kaplanski, C. Farnarier, M. Payan, P. Bongrand, and J. Durand, Increased levels of soluble adhesion molecules in the serum of patients with hepatitis C. Correlation with cytokine concentrations and liver inflammation and fibrosis, Digestive Diseases and Sciences, vol.42, issue.11, pp.2277-2284, 1997.
DOI : 10.1023/A:1018818801824

A. Zaman, H. Rosen, K. Ingram, C. Corless, E. Oh et al., Assessment of FIBROSpect II to Detect Hepatic Fibrosis in Chronic Hepatitis C Patients, The American Journal of Medicine, vol.120, issue.3, pp.280-289, 2007.
DOI : 10.1016/j.amjmed.2006.06.044

R. Thimme, Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease, Proceedings of the National Academy of Sciences, vol.99, issue.24, pp.15661-15668, 2002.
DOI : 10.1073/pnas.202608299

K. Boker, B. Pehle, C. Steinmetz, K. Breitenstein, M. Bahr et al., Tissue inhibitors of metalloproteinases in liver and serum/plasma in chronic active hepatitis C and HCV-induced cirrhosis, Hepatogastroenterology, vol.47, issue.33, pp.812-819, 2000.

M. Zeremski, Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C, Hepatology, vol.194, issue.Suppl 2, pp.1440-1450, 2008.
DOI : 10.1002/hep.22500

K. Ajami, Stromal cell-derived factors 1?? and 1??, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8, FEBS Letters, vol.383, issue.5, pp.819-825, 2008.
DOI : 10.1016/j.febslet.2008.02.005

B. Bauvois, Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis?, Oncogene, vol.23, issue.2, pp.317-329, 2004.
DOI : 10.1038/sj.onc.1207124

J. Cox, R. Dean, C. Roberts, and C. Overall, Matrix Metalloproteinase Processing of CXCL11/I-TAC Results in Loss of Chemoattractant Activity and Altered Glycosaminoglycan Binding, Journal of Biological Chemistry, vol.283, issue.28, pp.19389-19399, 2008.
DOI : 10.1074/jbc.M800266200

A. Lambeir, Kinetic Investigation of Chemokine Truncation by CD26/Dipeptidyl Peptidase IV Reveals a Striking Selectivity within the Chemokine Family, Journal of Biological Chemistry, vol.276, issue.32, pp.29839-29845, 2001.
DOI : 10.1074/jbc.M103106200

G. Firneisz, P. Lakatos, and F. Szalay, Serum Dipeptidyl Peptidase IV (DPP IV, CD26) Activity in Chronic Hepatitis C, Scandinavian Journal of Gastroenterology, vol.36, issue.8, pp.877-880, 2001.
DOI : 10.1080/003655201750313423

S. Yang, L. Fu, C. Chang, H. Yeh, G. Chen et al., Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C, Journal of Gastroenterology and Hepatology, vol.14, issue.12, pp.1789-1793, 2006.
DOI : 10.1006/cyto.1999.0653

D. Souza, R. Sabin, C. Foster, and G. , Insulin Resistance Plays a Significant Role in Liver Fibrosis in Chronic Hepatitis C and in the Response to Antiviral Therapy, The American Journal of Gastroenterology, vol.27, issue.11, pp.1509-1515, 2005.
DOI : 10.1002/hep.510290401

M. Romero-gomez, Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients, Gastroenterology, vol.128, issue.3, pp.636-641, 2005.
DOI : 10.1053/j.gastro.2004.12.049

M. Romero-gomez, Insulin resistance and hepatitis C, World Journal of Gastroenterology, vol.12, issue.44, pp.7075-7080, 2006.
DOI : 10.3748/wjg.v12.i44.7075

URL : https://hal.archives-ouvertes.fr/hal-00646005

T. Chowdhury and B. Hossain, New drugs for the treatment of type 2 diabetes, British Journal of Hospital Medicine, vol.68, issue.4, pp.178-183, 2007.
DOI : 10.12968/hmed.2007.68.4.178

F. Negro, Insulin resistance and HCV: Will new knowledge modify clinical management?, Journal of Hepatology, vol.45, issue.4, pp.514-519, 2006.
DOI : 10.1016/j.jhep.2006.07.011

M. Romero-gomez, Treatment of insulin resistance with metformin in na??ve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin, Hepatology, vol.1, issue.Suppl, pp.1702-1708, 2009.
DOI : 10.1002/hep.23206

U. Christen, V. Herrath, and M. , IP-10 and Type 1 Diabetes: A Question of Time and Location, Autoimmunity, vol.53, issue.4, pp.273-282, 2004.
DOI : 10.1016/S0167-5699(98)01346-2

G. Sitia, M. Isogawa, M. Iannacone, I. Campbell, F. Chisari et al., MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs, Journal of Clinical Investigation, vol.113, issue.8, pp.1158-1167, 2004.
DOI : 10.1172/JCI200421087